Nanjing’s investor landscape includes technology managers, municipal direct-investment routes and China-wide venture specialists. A useful shortlist shows which one fits the next step from research or an early product to a stronger commercial company.
Compare 15 routes by connection, stage and sector, then use the worked example and copyable worksheet to build a more useful first research wave.
Match a Nanjing capital route to the company’s evidence
| Your situation | Research first | Prepare or clarify |
|---|---|---|
| An industrial technology needs a relevant Jiangsu manager | Addor, Jolmo or a suitable national hard-tech fund | The product, technical validation and current fund’s entry stage |
| A local science company needs a direct-investment platform | Nanjing Innovation Investment / Zijin Kechuang family | Which direct-company vehicle fits; do not use a GP-selection process |
| A software team is building repeatable enterprise demand | Eminence, Jingwei or Gobi China | Deployment, adoption and an identifiable business buyer |
| A company needs early technical conviction | Ivy, Linear, Vertex China or ZhenFund | Technical differentiation, founder capability and the next proof point |
Choose a small first wave you can research well. Save one current, source-backed reason for fit and one question to resolve for each investor. The aim is a better next conversation, not the longest possible spreadsheet.
Compare 15 investor routes
This is a selective, unranked comparison of investment organizations and clearly identified investor networks. Local connection, country focus and investment eligibility are different facts. The wider names are not all Nanjing offices. On a small screen, scroll the table sideways to compare columns.
| Investor or network | Connection | Stage distinction | Company focus |
|---|---|---|---|
| Addor Capital | Local connection: Nanjing / Jiangsu investment ecosystem | Technology investment; vehicle-specific | Technology and industrial innovation |
| Jolmo Capital / Golden Rainforest | Local connection: Nanjing-based; Jiangsu and wider China | Angel, venture and other equity vehicles; fund-specific | Materials; manufacturing; energy; healthcare; semiconductors |
| Nanjing Innovation Investment / Zijin technology-investment family | Local connection: Nanjing-local; Zijin Kechuang grouped with its parent | Early technology and other direct-investment vehicles | Nanjing technology commercialization and industrial development |
| Ivy Capital | Wider-market mandate: Founded in Shanghai with Shanghai and Hong Kong context | Early investment with follow-on activity | AI infrastructure; advanced materials; photonics; other deep technology |
| Qiming Venture Partners | Wider-market mandate: China venture investment platform | Early and growth stages | Technology and healthcare innovation |
| Vertex Ventures China | Wider-market mandate: China team with Beijing, Shanghai and Shenzhen offices | Early-stage investments; fund-specific | Technology; advanced manufacturing; biomedicine |
| Linear Capital | Wider-market mandate: China-linked technology investor with international examples | Angel through Series A | AI software and hardware; science and manufacturing |
| Jingwei Venture Capital | Wider-market mandate: China-focused strategy in its Chinese-language overview | Early and early-growth stages | Software; technology; advanced manufacturing; consumer |
| Soul Capital | Wider-market mandate: Explicit China-focused early-stage strategy | Early stage | Technology startups |
| Gobi China | Wider-market mandate: China team based in Shanghai and Beijing | Early stage; vehicle-specific | Technology businesses |
| Lighthouse Yuanzhan Capital | Wider-market mandate: China-based manager with China and US startup activity | Early stage | Technology products and commercialization |
| Eminence Ventures | Wider-market mandate: Published China enterprise-cloud focus | Early stage | Enterprise software and cloud computing |
| Legend Capital | Wider-market mandate: Shenzhen office | Early venture and growth strategies differ | Technology; enterprise; manufacturing; health and other themes |
| Shenzhen Capital Group | Wider-market mandate: Shenzhen base; nationwide investment network | Early and growth VC/PE strategies differ | Information technology; advanced manufacturing; healthcare; materials; energy |
| ZhenFund | Wider-market mandate: Beijing-rooted founder and technology ecosystem | Early stage | Technology across sectors |
How is this different from the China investor guide?
The national guide is the starting point for broad manager research. This page adds Nanjing’s local investment identities and the practical question of direct-company versus fund-allocation access. Addor, Jolmo and the Nanjing Innovation Investment family are not interchangeable routes.
Compare them with national specialists only after identifying the company’s product and milestone. A locally connected investor may offer useful context, while a national fund may have a more specific sector thesis. Neither advantage eliminates the need to confirm current entry criteria.
Which Nanjing investment names should be grouped?
Jolmo, Golden Rainforest and the former Jiangsu Jinmao brand refer to one manager family here. Nanjing Innovation Investment and its Zijin technology-investment entities are also grouped conservatively. A rebrand or subsidiary should not produce another round of the same outreach.
Municipal platforms can manage direct-investment funds, funds of funds and secondary strategies. Use the official project channel for the relevant company-investment vehicle. A request for fund-manager proposals is not a startup fundraising form.
What should a scientific founder prepare before the first meeting?
Separate scientific novelty, product performance and customer adoption. A semiconductor tool, a new material and a medical product can all be technology businesses, but the next validation milestone differs. Explain what the requested capital will allow the company to prove.
Bring a shareable technical summary, a commercialization plan and specific unanswered questions. Keep confidential diligence documents for a mutually agreed next step. The goal of an initial conversation is to establish real fit, not to send the maximum amount of material.
15 investors and networks to research
1. Addor Capital
Venture and equity manager. Addor is an established participant in Nanjing’s technology-investment ecosystem, with current municipal reporting identifying its role in the city’s capital network. Research the specific fund and technical-investment team rather than treating every Addor vehicle or its historical institutional relationships as separate investor families.
Public approach: Use the official manager’s current company-contact route; confirm the active fund. Official source.
2. Jolmo Capital / Golden Rainforest
Venture and private-equity manager. Jolmo’s public company overview separates angel, venture and other private-equity vehicles. Its investment themes include new materials, manufacturing, energy, healthcare and semiconductor technology. Golden Rainforest, Jolmo and the former Jiangsu Jinmao name are treated as one manager family, not three independent prospects.
Public approach: Review the current official company information and its founder/contact navigation; a separate open submission form was not verified. Official source.
3. Nanjing Innovation Investment / Zijin technology-investment family
Municipal direct-equity and fund platform. Nanjing Innovation Investment publishes direct-investment funds separately from its fund-of-funds and secondary strategies. Zijin Kechuang belongs within this family for shortlist purposes. A founder should identify the direct-company route, stage and local commercialization connection, not submit a company pitch to a GP selection process.
Public approach: Use the official project-submission channel; select a direct-investment vehicle. Official source.
4. Ivy Capital
Deep-technology venture investor. Ivy states an AI and deep-tech focus. Explain the technical evidence and commercial use case, then confirm the company's geographic and fund fit.
Public approach: Official investment information. Official source.
5. Qiming Venture Partners
Venture investment manager. Qiming's Chinese-language overview distinguishes technology and healthcare. Match the actual product and stage to the relevant team instead of assuming a portfolio company's later round defines initial entry.
Public approach: Official investment information. Official source.
6. Vertex Ventures China
China venture fund team. Vertex describes independently operated regional fund teams. Select the China team and current vehicle rather than assuming every Vertex fund shares the same mandate.
Public approach: Official investment information. Official source.
7. Linear Capital
Frontier-technology venture investor. Linear describes angel-to-Series-A investment and a frontier-technology focus. A past international portfolio company does not establish that every geography or company structure is eligible.
Public approach: Official investment information. Official source.
8. Jingwei Venture Capital
China venture investment manager. Jingwei's official overview describes early and early-growth investing in China. Confirm the relevant investment team and current route; historical brand associations are not separate investors.
Public approach: Official investment information. Official source.
9. Soul Capital
Early-stage venture investor. Soul's official English overview describes early-stage technology companies in China. Prepare the technical differentiation and the operating market before asking about the current vehicle.
Public approach: Official investment information. Official source.
10. Gobi China
Early-stage venture manager. Gobi China describes China-based early-stage funds. Count the China manager once; a similarly named regional or Pakistan venture team is not automatically the same fund.
Public approach: Official investment information. Official source.
11. Lighthouse Yuanzhan Capital
Early-stage venture investor. This is Lighthouse Yuanzhan Capital, not similarly named firms in other markets. Its published approach connects technology with commercialization; verify the current fund and founder route.
Public approach: Official investment information. Official source.
12. Eminence Ventures
Enterprise-cloud venture firm. Eminence describes early-stage enterprise software and cloud investing in China. Separate actual business-customer use from a generic AI or software label.
Public approach: Official investment information. Official source.
13. Legend Capital
Venture and growth private-equity manager. Legend’s current site separates early venture from growth private equity and publishes several sector strategies. Identify the company’s actual stage, sector and relevant team before approaching the manager. Fundraising into a fund and a company seeking investment are different enquiries.
Public approach: Use official team/contact information; do not assume an LP contact is a company pitch route. Official source.
14. Shenzhen Capital Group
Venture and private-capital manager. SCGC’s current overview emphasizes venture capital and hard technology across China. A company seeking equity should identify the direct-investment team rather than its fund-of-funds, public-market or other asset activities. Government-related fund commitments are not extra startup investors in this list.
Public approach: Use the current official team/contact route. Official source.
15. ZhenFund
Early-stage venture firm. ZhenFund’s current About page states an early-stage founder thesis and publishes a BP submission address. Explain the team’s insight and what the product has established. The investment route is distinct from the firm’s media, events and recruiting enquiries.
Public approach: Use the published BP route, not media contact. Official source.
Worked example: a Nanjing semiconductor-equipment team
Fictional worked example. A fictional team has demonstrated equipment in a research setting and is preparing a customer-site evaluation. Its next milestone is to establish performance and integration requirements in that setting. The shortlist should combine relevant industrial-technology managers with early venture funds comfortable evaluating technical differentiation.
| Candidate lane | Next action | Why it changes the decision |
|---|---|---|
| Addor or Jolmo | Identify the relevant technology team and current vehicle | A manager may operate different stage and instrument strategies |
| Nanjing direct-investment family | Confirm the company-investment route and local project fit | The municipal platform also performs allocator functions |
| Ivy, Linear or Vertex China | Connect technical proof with the first commercial evaluation | Research novelty alone is not a complete venture case |
Keep the round tied to a concrete next milestone. Use the round-size planning worksheet to organize assumptions before committing to an outreach target.
Build your Nanjing investor-fit worksheet
Use one card per investment family and strategy. The worksheet works in a document, spreadsheet or your Finta research notes. Separate verified facts, assumptions and unanswered questions so the next action is clear.
INVESTOR FIT CARD: NANJING
Company and next funding milestone: [authorized company facts]
Manager identity / historical brand: [one family, one outreach owner]
Scientific and customer evidence: [separate what each proves]
Direct-company route: [current vehicle and official project destination]
Investor family and specific vehicle: [current name; avoid duplicates]
Official stage, sector and geography: [source URL and research date]
Fit evidence: [what actually matches the company today]
Mismatch or unresolved question: [what remains unknown]
Investor role: [lead / participant / unknown; source or direct confirmation]
Approach: [public founder route / company contact / permitted introduction]
Relationship context: [known person; permission to ask; no assumed introduction]
Owner, next action and follow-up date: [person; task; date]Bring the shortlist into Finta to connect investor research, relationship context, conversations and follow-up. Aurora can help organize the context and prepare the next steps for your review. You stay in control of the approach and information shared.
Review the shortlist with Aurora, Claude or Codex
Use public sources and company information you are authorized to share. Check the output against those sources before acting.
Help me build an evidence-backed investor shortlist for a Nanjing startup.
Company, location, current evidence and next funding milestone: [authorized facts]
Candidates and official sources: [names, URLs and research dates]
Separate local presence, country focus, regional mandate and actual company eligibility.
Check the current investment family, vehicle, entry stage, sector and public founder route.
Distinguish equity investors, angel networks, investing accelerators, grants, lending and services.
Do not infer current eligibility from an old portfolio investment or a nearby office.
Return a table: investor, fit evidence, mismatch, unknown, next question and action owner.
Suggest a small first research wave and explain exclusions.
Keep missing or contradictory facts as unknown; do not invent check sizes or lead behavior.
Do not contact anyone, submit applications or share confidential information.Connect the shortlist to the rest of your raise
For a broader starting point, see Venture Capital Firms in China: 18 Investors and Funding Routes. Then connect the research to your pre-seed preparation, the Seed Fundraising Comprehensive Guide and the investor-prospecting workflow.
Keep one owner and a clear next step for each investor conversation. A well-researched shortlist becomes valuable when source evidence, the right relationship context and thoughtful follow-through stay connected.
Methodology and research date
By Finta Editorial Team. Official investor and institutional materials reviewed 2026-11-13. This guide includes 15 investment families or clearly identified investor networks. It is not a ranking of returns, popularity or likelihood of funding.
Names, investment roles and stated strategies were checked against official materials linked in the profiles. Related vehicles and rebrands are grouped conservatively. A local connection, a wider investment mandate and company eligibility are different facts. Where an initial stage, current vehicle or intake is unspecified, it remains a question for the investor.
The Startup Genome ecosystem research helps frame the city opportunity; an ecosystem ranking or profile is not investor eligibility evidence. The cover is an editorial ecosystem illustration, not a map of investor offices or actual financing flows.
What is kept separate:
- Jolmo / Golden Rainforest / historical Jinmao branding is counted once.
- Nanjing Innovation Investment and Zijin Kechuang-related vehicles are grouped.
- Fund-of-funds allocations and GP selection are kept separate from startup equity investment.
General educational information, not a personal investment recommendation. Confirm the current company and fund requirements before approaching an investor.